5 Key Takeaways

• 1

  Next-generation sequencing (NGS) is essential for precision oncology, but labs face challenges in efficiency and scalability.

• 2

  A study compared amplicon-based NGS and hybrid-capture workflows, revealing significant efficiency gains from workflow redesign.

• 3

  The Oncomine Dx Express Test demonstrated a 62-hour reduction in turnaround time compared to the hybrid-capture system.

• 4

  Automation in NGS workflows can reduce hands-on time and support faster, more efficient testing processes.

• 5

  Identifying and eliminating bottlenecks in NGS workflows is crucial for labs to meet increasing testing demands without compromising quality.